Hepatocyte Micro-Reactor (p5.js Kinetics)
T+ 0.0 hrs
Glutathione (GSH)
100.0%
Critical: <30%
NAPQI Electrophile
0.0 µM
Adduct forming
Phase II Saturation
18.4%
Vmax capacity
Hepatocyte Viability
100.0%
Membrane intact
Acute Acetaminophen Dose
8,000 mg
CYP2E1 Activity Multiplier (Ethanol / Fasting)
1.4x
Dose Administration Pattern
Single Bolus
Simulation Speed
1.0x Realtime
N-Acetylcysteine (NAC) Antidote Protocol
Glutathione substrate donor is currently inactive. Deliver to replenish GSH pool.
Real-time Kinetic Trajectories (0 - 24 Hours)
APAP Serum (mg/L)
GSH Reserve (%)
Toxic NAPQI (µM)
Necrotic Index (%)
U.S. DILIN Epidemiological Longitudinal Data >400% Rise Since 2000
- Acetaminophen (APAP): Now #1 leading cause of acute liver failure (ALF) in the US (~50% of all ALF cases), having surpassed alcohol and viral hepatitis.
- Inadvertent Staggered Overdose: ~48% of APAP poisonings occur unintentionally through multi-product combination formulations (cough/cold syrups + pain relievers).
- Mechanistic Pathway: Glucuronidation (UGT) and Sulfation (SULT) saturate at >4,000mg/24h. Excess flux redirects to CYP2E1, synthesizing electrophilic NAPQI which covalently binds mitochondrial proteins once GSH drops <30%.